Rochester, NY 7/11/2009 2:17:34 AM
Stock Market Update - DYAX - UPDATE 1-Dyax to raise $14 mln in public share offering
Dyax Corp.,DYAX
Stock Market Update - DYAX - UPDATE 1-Dyax to raise $14 mln in public share offering
---
Dyax Corp.,DYAX
Last Trade: 3.05
Day's Range: 2.81 - 3.06
52wk Range: 1.55 - 5.35
Volume: 175,740
COMPANY "In The News"
Dyax Corp said it would sell 7.4 million common shares at $2.02 a share in an underwritten public offering with no warrants, and expects to raise net proceeds of about $14 million. The company said it has granted the underwriter, Deutsche Bank Securities Inc, a 30-day option to buy up to an additional 1.1 million common shares to cover over-allotments, if any.
COMPANY DETAILS
Dyax Corp., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of biotherapeutics for oncology and inflammatory indications. The company uses phage display, a drug discovery technology to identify antibody, small protein, and peptide compounds for clinical development. It offers DX-88, an ecallantide, which is in late stage clinical trial development in two indications.
---
At WhisperfromWallStreet.com we specialize in understand the markets, particularly the penny stock market and understand what makes penny stocks increase. In a word it is exposure and by that we mean making the investing public aware of a particular stock, via an investor awareness campaign. Our tracking is second to none with our alerts in 2009 producing an average price gain of 80%+. If you'd like to track our results or receive your own alerts based on our experience, sign up now at... WhisperfromWallStreet.com
---
It's important that every investor be aware of our disclaimer which can be read in its entirety :
http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
